Haleon (NYSE:HLN) Stock Rating Lowered by Morgan Stanley

Haleon (NYSE:HLN) was downgraded by equities researchers at Morgan Stanley from an “overweight” rating to an “equal weight” rating in a research report issued to clients and investors on Friday,Briefing.com Automated Import reports.

A number of other equities analysts have also recently issued reports on HLN. Sanford C. Bernstein cut Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday. UBS Group upgraded Haleon to a “strong-buy” rating in a research report on Tuesday, October 1st. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $10.95.

Haleon Stock Performance

NYSE HLN opened at $9.50 on Friday. Haleon has a twelve month low of $7.89 and a twelve month high of $10.80. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. The stock has a market cap of $43.00 billion, a P/E ratio of 27.94, a PEG ratio of 2.95 and a beta of 0.29. The company’s 50-day simple moving average is $9.61 and its 200 day simple moving average is $9.67.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. AE Wealth Management LLC raised its position in Haleon by 6.1% in the 2nd quarter. AE Wealth Management LLC now owns 19,199 shares of the company’s stock valued at $159,000 after purchasing an additional 1,098 shares during the last quarter. Lake Street Advisors Group LLC increased its stake in shares of Haleon by 5.4% in the third quarter. Lake Street Advisors Group LLC now owns 22,395 shares of the company’s stock valued at $237,000 after buying an additional 1,143 shares in the last quarter. Synovus Financial Corp raised its holdings in shares of Haleon by 0.8% in the third quarter. Synovus Financial Corp now owns 148,834 shares of the company’s stock valued at $1,575,000 after buying an additional 1,216 shares during the last quarter. Hexagon Capital Partners LLC lifted its position in Haleon by 18.5% during the 3rd quarter. Hexagon Capital Partners LLC now owns 7,933 shares of the company’s stock worth $84,000 after buying an additional 1,238 shares in the last quarter. Finally, Brown Brothers Harriman & Co. grew its holdings in Haleon by 21.4% during the 2nd quarter. Brown Brothers Harriman & Co. now owns 7,569 shares of the company’s stock worth $63,000 after acquiring an additional 1,334 shares during the last quarter. 6.67% of the stock is owned by institutional investors and hedge funds.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.